Overcoming Late Stage Formulations & Manufacturing Challenges with KinetiSol Technology

In this Xtalks webinar, Dr. Dave Miller, Chief Scientific Officer at AustinPx, explores how KinetiSol™ Technology helps sponsors overcome the formulation and manufacturing hurdles that often appear late in development. Traditional spray drying methods can introduce variability, high costs, and scale-up challenges, but KinetiSol offers a solvent-free alternative that delivers consistent performance and improved manufacturability.

Through real-world examples, Dr. Miller demonstrates how KinetiSol produces dense, directly compressible amorphous solid dispersions that reduce pill burden, improve bioavailability, and streamline the path to commercialization. The result is a faster, more sustainable route to market for complex molecules once considered too difficult to develop.